Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study)

被引:5
|
作者
Puleo, Christopher W. [1 ]
Ayers, Colby R. [2 ]
Garg, Sonia [2 ]
Neeland, Ian J. [2 ]
Lewis, Alana A. [2 ]
Pandey, Ambarish [2 ]
Drazner, Mark H. [2 ]
de Lemos, James A. [2 ]
机构
[1] Ochsner Med Ctr, Heart & Vasc Inst, 1514 Jefferson Highway, New Orleans, LA 70121 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
biostatistics; cardiology; heart failure; NATRIURETIC PEPTIDE LEVELS; LEFT-VENTRICULAR HYPERTROPHY; C-REACTIVE PROTEIN; ATHEROSCLEROSIS RISK; GENERAL-POPULATION; PROGNOSTIC VALUE; IMPACT; ASSAY; MORTALITY; FAILURE;
D O I
10.2217/bmm-2021-0055
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) associate with structural heart disease and heart failure risk in individuals without known cardiovascular disease (CVD). However, few data are available regarding whether factors influencing levels of these two biomarkers are similar or distinct. We performed serial measurement of NT-proBNP and hs-cTnT in a contemporary multiethnic cohort with extensive phenotyping, with the goal of identifying their respective biological determinants in a population without known or suspected CVD. Methods: We evaluated 1877 participants of the Dallas Heart Study who had NT-proBNP and hs-cTnT measured and were free from clinical CVD at the each of its two examinations (2000-2002 and 2007-2009). Variables collected included demographic and risk factors, high-sensitivity C-reactive protein, body composition via dual-energy x-ray absorptiometry, coronary artery calcium by computed tomography, and cardiac dimensions and function by cardiac MRI. Linear regression was used to identify associations of these factors with each biomarker at baseline and with changes in biomarkers over follow-up. Results: NT-proBNP and hs-cTnT were poorly correlated at baseline (Spearman rho 0.083, p = 0.015), with only moderate correlation between change values (rho 0.18, p < 0.001). hs-cTnT positively associated and NT-proBNP inversely associated with male gender and black race. At baseline, both NT-proBNP and hs-cTnT associated with left ventricular end-diastolic volume and wall thickness, but only NT-proBNP associated with left atrial size. Changes in cardiac dimensions between phases were more strongly associated with changes in NT-proBNP than hs-cTnT. NT-proBNP was more strongly associated with high-sensitivity C-reactive protein and measures of body composition than hs-cTnT. Conclusion: Among individuals without CVD in the general population, NT-proBNP and hs-cTnT are nonredundant biomarkers that are differentially associated with demographic and cardiac factors. These findings indicate that hs-cTnT and NT-proBNP may reflect different pathophysiological pathways.
引用
收藏
页码:1487 / 1498
页数:12
相关论文
共 50 条
  • [31] Interpretation of elevated baseline concentrations and serial changes of high-sensitivity cardiac troponin T in confirmed muscular dystrophies
    Yildirim, Mustafa
    Reich, Christoph
    Salbach, Christian
    Pribe-Wolferts, Regina
    Milles, Barbara Ruth
    Taeger, Tobias
    Mueller-Hennessen, Matthias
    Weiler, Markus
    Meder, Benjamin
    Frey, Norbert
    Giannitsis, Evangelos
    ESC HEART FAILURE, 2024, 11 (06): : 3732 - 3741
  • [32] Predictive Value of Baseline Serum High-Sensitivity Troponin I and NT-proBNP for Cardiac Immunotoxicity Risk During Immune Checkpoint Inhibitor Therapy
    Rao, Anjali
    Prasad, Tanushree
    Simon, Shayna
    Zhu, Hong
    Venkatesh, Vishnu
    Ali, Sadia
    Bermas, Bonnie
    Bernabela, Luigino
    Bhai, Salman
    Brugarolas, James
    Castillo, Pedro
    Chandra, Alvin
    Dao, Kathryn
    Mammen, Pradeep P.
    Garg, Sonia
    Homsi, Jade
    Oz, Orhan
    Ratti, Gregory
    Selby, Chris
    Vallabhaneni, Srilakshmi
    Zhang, Kathleen
    De Lemos, James A.
    Sweetenham, John
    Hammers, Hans
    Zaha, Vlad G.
    CIRCULATION, 2022, 146
  • [33] Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis
    Welsh, Paul
    Tuckwell, Katie
    McInnes, Iain B.
    Sattar, Naveed
    ATHEROSCLEROSIS, 2016, 254 : 167 - 171
  • [34] NT-proBNP and Cardiac Troponin I, but Not Cardiac Troponin T, Are Associated With 7-Year Changes in Cardiac Structure and Function in Older Adults: The ARIC Study
    Myhre, Peder L.
    Claggett, Brian
    Ballantyne, Christie M.
    Hoogeveen, Ron C.
    Selvin, Elizabeth
    Matsushita, Kunihiro
    Kitzman, Dalane
    Konety, Suma
    Mosley, Thomas
    Shah, Amil M.
    CIRCULATION, 2024, 150 (03) : 1647 - 1857
  • [35] The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T
    Metra, Marco
    Nodari, Savina
    Parrinello, Giovanni
    Specchia, Claudia
    Brentana, Loretta
    Rocca, Patrizia
    FracasSi, Francesco
    Bordonall, Tania
    Milani, Patrizia
    DaneSi, Rossella
    Verzura, Giulia
    Chiari, Ermanna
    Cas, Livio Dei
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (08) : 776 - 786
  • [36] High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australian population-based cohort
    Zhu, Kun
    Knuiman, Matthew
    Divitini, Mark
    Murray, Kevin
    Lim, Ee Mun
    St John, Andrew
    Walsh, John P.
    Hung, Joseph
    HEART, 2018, 104 (11) : 895 - 903
  • [37] EFFECT OF TOCILIZUMAB ON CARDIAC BIOMARKERS HIGH-SENSITIVITY TROPONIN T AND NT-PROBNP IN RHEUMATOID ARTHRITIS: POST HOC ANALYSIS OF A RANDOMISED CONTROLLED TRIAL
    Welsh, P.
    Tuckwell, K.
    Sattar, N.
    ATHEROSCLEROSIS, 2016, 252 : E58 - E58
  • [38] Circulating levels and prognostic cut-offs of sST2, high-sensitivity troponin T, and NT-proBNP in women vs. men with chronic heart failure
    Gentile, Francesco
    Aimo, Alberto
    Jannuzzi, James Lj, Jr.
    Richards, Mark
    Lam, Carolyn Sp
    De Boer, Rudolf A.
    Meems, Laura Mg
    Latini, Roberto
    Staszewsky, Lidia
    Anand, Inder S.
    Cohn, Jay N.
    Ueland, Thor
    Guellestad, Lars
    Aukrust, Pal
    Rocca, Hans-Peter Brunner-La
    Bayes-Genis, Antoni
    Lupon, Josep
    Yoshihisa, Akiomi
    Egstrup, Michael
    Gustafsson, Ida
    Gaggin, Hanna K.
    Eggers, Kai M.
    Huber, Kurt
    Gamble, Greg D.
    Ling, Lieng H.
    Leong, Kui Toh Gerard
    Yeo, Poh Shuah Daniel
    Ong, Hean Yee
    Jaufeerally, Fazlur
    Ng, Tze P.
    Troughton, Richard
    Doughty, Robert N.
    Devlin, Gerry
    Lund, Mayanna
    Giannoni, Alberto
    Passino, Claudio
    Emdin, Michele
    Vergaro, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [39] Circulating levels and prognostic cut-offs of sST2, high-sensitivity troponin T, and NT-proBNP in women vs. men with chronic heart failure
    Gentile, Francesco
    Aimo, Alberto
    Jannuzzi, James Lj
    Richards, Mark
    Lam, Carolyn Sp
    Boer, Rudolf A. De
    Meems, Laura Mg
    Latini, Roberto
    Staszewsky, Lidia
    Anand, Inder S.
    Cohn, Jay N.
    Ueland, Thor
    Guellestad, Lars
    Aukrust, Pal
    Rocca, Hans-peter Brunner-la
    Bayes-genis, Antoni
    Lupon, Josep
    Yoshihisa, Akiomi
    Egstrup, Michael
    Gustafsson, Ida
    Gaggin, Hanna K.
    Eggers, Kai M.
    Huber, Kurt
    Gamble, Greg D.
    Ling, Lieng H.
    Leong, Kui Toh Gerard
    Yeo, Poh Shuah Daniel
    Ong, Hean Yee
    Jaufeerally, Fazlur
    Ng, Tze P.
    Troughton, Richard
    Doughty, Robert N.
    Devlin, Gerry
    Lund, Mayanna
    Giannoni, Alberto
    Passino, Claudio
    Emdin, Michele
    Vergaro, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [40] Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort
    Welsh, Paul
    Preiss, David
    Shah, Anoop S., V
    McAllister, David
    Briggs, Andrew
    Boachie, Charles
    McConnachie, Alex
    Hayward, Caroline
    Padmanabhan, Sandosh
    Welsh, Claire
    Woodward, Mark
    Campbell, Archie
    Porteous, David
    Mills, Nicholas L.
    Sattar, Naveed
    CLINICAL CHEMISTRY, 2018, 64 (11) : 1607 - 1616